U.S. govt set to release plan to lower prescription drug prices
Economy2 hours ago (Sep 09, 2021 07:14AM ET)
© Reuters. FILE PHOTO: Prescriptions are filled at the Rock Canyon pharmacy in Provo, Utah, U.S., May 9, 2019. REUTERS/George Frey
(Reuters) – The Biden administration is set to unveil a plan that supports legislation to empower the U.S. federal government to negotiate drug prices in Medicare and pass along the benefits to the private sector, the Wall Street Journal reported https://on.wsj.com/3hbUEQL on Thursday.
The COVID-19 outbreak, which has upended the U.S. economy and so far killed about 649,299 people in the country, has drawn renewed attention to healthcare costs.
In August, President Biden said U.S. prescription drug costs were two to three times higher than other nations in the world, while urging lawmakers to enact legislation to lower drug prices.
The U.S. Medicare program is a health insurance program for people aged 65 and above, and those with disabilities.
The plan, to be released later on Thursday, will back legislation aimed at lowering drug prices put forth by congressional Democrats, the WSJ report said.
It will also outline other administrative measures such as testing reimbursement for drugs in Medicare based on the clinical value they provide to patients and federal funding for research into new treatments, the report said.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.